Randomized, double-blind, placebo-controlled trial of monthly injectable buprenorphine for methamphetamine use disorder (MURB) (CTN-0110)
$1,406,983N01FY2021DANIH
The Emmes Company, Llc, Rockville MD
Investigators
Abstract
Randomized, double-blind, placebo-controlled trial of monthly injectable buprenorphine for methamphetamine use disorder (MURB) (CTN-0110)
View original record on NIH RePORTER →